More on BMEA
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $1.84 |
|
|||
| Open | $1.83 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $1.84 | ||||
| Day Low | $1.68 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 2,051,612 | ||||
- Increasing unusual call volume: CYPH BMEA KHC DPRO CBRG NAVN TTAN RARE SOLZ TSSI AADX BEAM AVAV
- Biomea Fusion, Inc. (BMEA) January 2.5 calls active
- Increasing unusual call option volume: GPRO BMEA DPRO RARE INSW VSXY CHPT VRNS SYF EPYT
- Biomea Fusion to Participate in Upcoming Investor Conferences
- H.C. Wainwright on Biomea Fusion Inc. (BMEA) amid 17% Gain: 'Another step toward confirmatory Phase 2 data and T2D development strategy'
- Biomea Fusion completes enrollment in Phase II diabetes trial
- Biomea Fusion Announces Completion of Enrollment in COVALENT-211 Phase II Trial of Icovamenib in Insulin-Deficient Type 2 Diabetes
- Biomea Fusion doses first patient in obesity combo drug study
- Biomea Fusion Announces First Patient Dosed in OPAL Study Evaluating Icovamenib in Combination with Semaglutide in Obesity
- Citi opens 90-day Positive catalyst watch on Biomea Fusion
Entities mentioned with BMEA
- FDA | View Related Stories »
- Twitter | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Earnings | View Related Stories »
- JPMorgan | View Related Stories »
- 13G | View Related Stories »
- Show More...
